Short-term treatment outcomes in human immunodeficiency virus type-1 and hepatitis B virus co-infections.
Identifieur interne : 000146 ( Main/Exploration ); précédent : 000145; suivant : 000147Short-term treatment outcomes in human immunodeficiency virus type-1 and hepatitis B virus co-infections.
Auteurs : Kwamena William Coleman Sagoe [Ghana] ; Kwabena Obeng Duedu [Ghana] ; Francesca Ziga [Ghana] ; Afrakoma Adjoa Agyei [Ghana] ; Theophilus Korku Adiku [Ghana] ; Margaret Lartey [Ghana] ; Julius Abraham Addo Mingle [Ghana] ; Max Arens [États-Unis]Source :
- Annals of clinical microbiology and antimicrobials [ 1476-0711 ] ; 2016.
Descripteurs français
- KwdFr :
- ARN viral (antagonistes et inhibiteurs), ARN viral (génétique), ARN viral (sang), Adulte, Adulte d'âge moyen, Afrique de l'Ouest, Antiviraux (usage thérapeutique), Charge virale (), Co-infection, Facteurs sexuels, Femelle, Génotype, Humains, Hépatite B (immunologie), Hépatite B (traitement médicamenteux), Hépatite B (virologie), Infections à VIH (immunologie), Infections à VIH (traitement médicamenteux), Infections à VIH (virologie), Mâle, Numération des lymphocytes CD4, Résultat thérapeutique, Thérapie antirétrovirale hautement active, VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (), VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (croissance et développement), VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (génétique), Virus de l'hépatite B (), Virus de l'hépatite B (croissance et développement), Virus de l'hépatite B (génétique), Études longitudinales.
- MESH :
- antagonistes et inhibiteurs : ARN viral.
- croissance et développement : VIH-1 (Virus de l'Immunodéficience Humaine de type 1), Virus de l'hépatite B.
- génétique : ARN viral, VIH-1 (Virus de l'Immunodéficience Humaine de type 1), Virus de l'hépatite B.
- immunologie : Hépatite B, Infections à VIH.
- sang : ARN viral.
- traitement médicamenteux : Hépatite B, Infections à VIH.
- usage thérapeutique : Antiviraux.
- virologie : Hépatite B, Infections à VIH.
- Adulte, Adulte d'âge moyen, Afrique de l'Ouest, Charge virale, Co-infection, Facteurs sexuels, Femelle, Génotype, Humains, Mâle, Numération des lymphocytes CD4, Résultat thérapeutique, Thérapie antirétrovirale hautement active, VIH-1 (Virus de l'Immunodéficience Humaine de type 1), Virus de l'hépatite B, Études longitudinales.
English descriptors
- KwdEn :
- Adult, Africa, Western, Antiretroviral Therapy, Highly Active, Antiviral Agents (therapeutic use), CD4 Lymphocyte Count, Coinfection, Female, Genotype, HIV Infections (drug therapy), HIV Infections (immunology), HIV Infections (virology), HIV-1 (drug effects), HIV-1 (genetics), HIV-1 (growth & development), Hepatitis B (drug therapy), Hepatitis B (immunology), Hepatitis B (virology), Hepatitis B virus (drug effects), Hepatitis B virus (genetics), Hepatitis B virus (growth & development), Humans, Longitudinal Studies, Male, Middle Aged, RNA, Viral (antagonists & inhibitors), RNA, Viral (blood), RNA, Viral (genetics), Sex Factors, Treatment Outcome, Viral Load (drug effects).
- MESH :
- chemical , antagonists & inhibitors : RNA, Viral.
- chemical , blood : RNA, Viral.
- chemical , genetics : RNA, Viral.
- chemical , therapeutic use : Antiviral Agents.
- drug effects : HIV-1, Hepatitis B virus, Viral Load.
- drug therapy : HIV Infections, Hepatitis B.
- genetics : HIV-1, Hepatitis B virus.
- growth & development : HIV-1, Hepatitis B virus.
- immunology : HIV Infections, Hepatitis B.
- virology : HIV Infections, Hepatitis B.
- Adult, Africa, Western, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Coinfection, Female, Genotype, Humans, Longitudinal Studies, Male, Middle Aged, Sex Factors, Treatment Outcome.
Abstract
Co-infection of HIV with HBV is common in West Africa but little information is available on the effects of HBV on short-term therapy for HIV patients. A 28 day longitudinal study was conducted to examine short-term antiretroviral therapy (ART) outcomes in HIV infected individuals with HBV co-infection.
DOI: 10.1186/s12941-016-0152-2
PubMed: 27251610
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000717
- to stream PubMed, to step Curation: 000717
- to stream PubMed, to step Checkpoint: 000717
- to stream Ncbi, to step Merge: 000992
- to stream Ncbi, to step Curation: 000992
- to stream Ncbi, to step Checkpoint: 000992
- to stream Main, to step Merge: 000146
- to stream Main, to step Curation: 000146
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Short-term treatment outcomes in human immunodeficiency virus type-1 and hepatitis B virus co-infections.</title><author><name sortKey="Sagoe, Kwamena William Coleman" sort="Sagoe, Kwamena William Coleman" uniqKey="Sagoe K" first="Kwamena William Coleman" last="Sagoe">Kwamena William Coleman Sagoe</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Korle-Bu, P. O. Box KB173, Accra, Ghana. ksagoe@ug.edu.gh.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Korle-Bu, P. O. Box KB173, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName><orgName type="university">Université du Ghana</orgName></affiliation></author><author><name sortKey="Duedu, Kwabena Obeng" sort="Duedu, Kwabena Obeng" uniqKey="Duedu K" first="Kwabena Obeng" last="Duedu">Kwabena Obeng Duedu</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Korle-Bu, P. O. Box KB173, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Korle-Bu, P. O. Box KB173, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName><orgName type="university">Université du Ghana</orgName></affiliation></author><author><name sortKey="Ziga, Francesca" sort="Ziga, Francesca" uniqKey="Ziga F" first="Francesca" last="Ziga">Francesca Ziga</name><affiliation wicri:level="3"><nlm:affiliation>Pharmacy Department, Korle-Bu Teaching Hospital, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Pharmacy Department, Korle-Bu Teaching Hospital, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName></affiliation></author><author><name sortKey="Agyei, Afrakoma Adjoa" sort="Agyei, Afrakoma Adjoa" uniqKey="Agyei A" first="Afrakoma Adjoa" last="Agyei">Afrakoma Adjoa Agyei</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medicine and Therapeutics, School of Medicine and Dentistry, University of Ghana, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Department of Medicine and Therapeutics, School of Medicine and Dentistry, University of Ghana, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName><orgName type="university">Université du Ghana</orgName></affiliation></author><author><name sortKey="Adiku, Theophilus Korku" sort="Adiku, Theophilus Korku" uniqKey="Adiku T" first="Theophilus Korku" last="Adiku">Theophilus Korku Adiku</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Korle-Bu, P. O. Box KB173, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Korle-Bu, P. O. Box KB173, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName><orgName type="university">Université du Ghana</orgName></affiliation></author><author><name sortKey="Lartey, Margaret" sort="Lartey, Margaret" uniqKey="Lartey M" first="Margaret" last="Lartey">Margaret Lartey</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medicine and Therapeutics, School of Medicine and Dentistry, University of Ghana, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Department of Medicine and Therapeutics, School of Medicine and Dentistry, University of Ghana, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName><orgName type="university">Université du Ghana</orgName><placeName><settlement type="city">Accra</settlement><settlement type="town">Legon (Ghana)</settlement><region type="region">Région du Grand Accra</region></placeName><orgName type="university" n="3">Université du Ghana</orgName></affiliation></author><author><name sortKey="Mingle, Julius Abraham Addo" sort="Mingle, Julius Abraham Addo" uniqKey="Mingle J" first="Julius Abraham Addo" last="Mingle">Julius Abraham Addo Mingle</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Korle-Bu, P. O. Box KB173, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Korle-Bu, P. O. Box KB173, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName><orgName type="university">Université du Ghana</orgName></affiliation></author><author><name sortKey="Arens, Max" sort="Arens, Max" uniqKey="Arens M" first="Max" last="Arens">Max Arens</name><affiliation wicri:level="2"><nlm:affiliation>Retrovirus Laboratory, Department of Pediatrics, Washington University Medical School, St. Louis, MO, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Retrovirus Laboratory, Department of Pediatrics, Washington University Medical School, St. Louis, MO</wicri:regionArea><placeName><region type="state">Missouri (État)</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27251610</idno><idno type="pmid">27251610</idno><idno type="doi">10.1186/s12941-016-0152-2</idno><idno type="wicri:Area/PubMed/Corpus">000717</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000717</idno><idno type="wicri:Area/PubMed/Curation">000717</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000717</idno><idno type="wicri:Area/PubMed/Checkpoint">000717</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000717</idno><idno type="wicri:Area/Ncbi/Merge">000992</idno><idno type="wicri:Area/Ncbi/Curation">000992</idno><idno type="wicri:Area/Ncbi/Checkpoint">000992</idno><idno type="wicri:Area/Main/Merge">000146</idno><idno type="wicri:Area/Main/Curation">000146</idno><idno type="wicri:Area/Main/Exploration">000146</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Short-term treatment outcomes in human immunodeficiency virus type-1 and hepatitis B virus co-infections.</title><author><name sortKey="Sagoe, Kwamena William Coleman" sort="Sagoe, Kwamena William Coleman" uniqKey="Sagoe K" first="Kwamena William Coleman" last="Sagoe">Kwamena William Coleman Sagoe</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Korle-Bu, P. O. Box KB173, Accra, Ghana. ksagoe@ug.edu.gh.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Korle-Bu, P. O. Box KB173, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName><orgName type="university">Université du Ghana</orgName></affiliation></author><author><name sortKey="Duedu, Kwabena Obeng" sort="Duedu, Kwabena Obeng" uniqKey="Duedu K" first="Kwabena Obeng" last="Duedu">Kwabena Obeng Duedu</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Korle-Bu, P. O. Box KB173, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Korle-Bu, P. O. Box KB173, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName><orgName type="university">Université du Ghana</orgName></affiliation></author><author><name sortKey="Ziga, Francesca" sort="Ziga, Francesca" uniqKey="Ziga F" first="Francesca" last="Ziga">Francesca Ziga</name><affiliation wicri:level="3"><nlm:affiliation>Pharmacy Department, Korle-Bu Teaching Hospital, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Pharmacy Department, Korle-Bu Teaching Hospital, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName></affiliation></author><author><name sortKey="Agyei, Afrakoma Adjoa" sort="Agyei, Afrakoma Adjoa" uniqKey="Agyei A" first="Afrakoma Adjoa" last="Agyei">Afrakoma Adjoa Agyei</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medicine and Therapeutics, School of Medicine and Dentistry, University of Ghana, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Department of Medicine and Therapeutics, School of Medicine and Dentistry, University of Ghana, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName><orgName type="university">Université du Ghana</orgName></affiliation></author><author><name sortKey="Adiku, Theophilus Korku" sort="Adiku, Theophilus Korku" uniqKey="Adiku T" first="Theophilus Korku" last="Adiku">Theophilus Korku Adiku</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Korle-Bu, P. O. Box KB173, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Korle-Bu, P. O. Box KB173, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName><orgName type="university">Université du Ghana</orgName></affiliation></author><author><name sortKey="Lartey, Margaret" sort="Lartey, Margaret" uniqKey="Lartey M" first="Margaret" last="Lartey">Margaret Lartey</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medicine and Therapeutics, School of Medicine and Dentistry, University of Ghana, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Department of Medicine and Therapeutics, School of Medicine and Dentistry, University of Ghana, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName><orgName type="university">Université du Ghana</orgName><placeName><settlement type="city">Accra</settlement><settlement type="town">Legon (Ghana)</settlement><region type="region">Région du Grand Accra</region></placeName><orgName type="university" n="3">Université du Ghana</orgName></affiliation></author><author><name sortKey="Mingle, Julius Abraham Addo" sort="Mingle, Julius Abraham Addo" uniqKey="Mingle J" first="Julius Abraham Addo" last="Mingle">Julius Abraham Addo Mingle</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Korle-Bu, P. O. Box KB173, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Korle-Bu, P. O. Box KB173, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName><orgName type="university">Université du Ghana</orgName></affiliation></author><author><name sortKey="Arens, Max" sort="Arens, Max" uniqKey="Arens M" first="Max" last="Arens">Max Arens</name><affiliation wicri:level="2"><nlm:affiliation>Retrovirus Laboratory, Department of Pediatrics, Washington University Medical School, St. Louis, MO, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Retrovirus Laboratory, Department of Pediatrics, Washington University Medical School, St. Louis, MO</wicri:regionArea><placeName><region type="state">Missouri (État)</region></placeName></affiliation></author></analytic><series><title level="j">Annals of clinical microbiology and antimicrobials</title><idno type="eISSN">1476-0711</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Africa, Western</term><term>Antiretroviral Therapy, Highly Active</term><term>Antiviral Agents (therapeutic use)</term><term>CD4 Lymphocyte Count</term><term>Coinfection</term><term>Female</term><term>Genotype</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (immunology)</term><term>HIV Infections (virology)</term><term>HIV-1 (drug effects)</term><term>HIV-1 (genetics)</term><term>HIV-1 (growth & development)</term><term>Hepatitis B (drug therapy)</term><term>Hepatitis B (immunology)</term><term>Hepatitis B (virology)</term><term>Hepatitis B virus (drug effects)</term><term>Hepatitis B virus (genetics)</term><term>Hepatitis B virus (growth & development)</term><term>Humans</term><term>Longitudinal Studies</term><term>Male</term><term>Middle Aged</term><term>RNA, Viral (antagonists & inhibitors)</term><term>RNA, Viral (blood)</term><term>RNA, Viral (genetics)</term><term>Sex Factors</term><term>Treatment Outcome</term><term>Viral Load (drug effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>ARN viral (antagonistes et inhibiteurs)</term><term>ARN viral (génétique)</term><term>ARN viral (sang)</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Afrique de l'Ouest</term><term>Antiviraux (usage thérapeutique)</term><term>Charge virale ()</term><term>Co-infection</term><term>Facteurs sexuels</term><term>Femelle</term><term>Génotype</term><term>Humains</term><term>Hépatite B (immunologie)</term><term>Hépatite B (traitement médicamenteux)</term><term>Hépatite B (virologie)</term><term>Infections à VIH (immunologie)</term><term>Infections à VIH (traitement médicamenteux)</term><term>Infections à VIH (virologie)</term><term>Mâle</term><term>Numération des lymphocytes CD4</term><term>Résultat thérapeutique</term><term>Thérapie antirétrovirale hautement active</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) ()</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (croissance et développement)</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (génétique)</term><term>Virus de l'hépatite B ()</term><term>Virus de l'hépatite B (croissance et développement)</term><term>Virus de l'hépatite B (génétique)</term><term>Études longitudinales</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>RNA, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>RNA, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>RNA, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term></keywords><keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>ARN viral</term></keywords><keywords scheme="MESH" qualifier="croissance et développement" xml:lang="fr"><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term><term>Virus de l'hépatite B</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>HIV-1</term><term>Hepatitis B virus</term><term>Viral Load</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term><term>Hepatitis B</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>HIV-1</term><term>Hepatitis B virus</term></keywords><keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>HIV-1</term><term>Hepatitis B virus</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>ARN viral</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term><term>Virus de l'hépatite B</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Hépatite B</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HIV Infections</term><term>Hepatitis B</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>ARN viral</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Hépatite B</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Hépatite B</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>HIV Infections</term><term>Hepatitis B</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Africa, Western</term><term>Antiretroviral Therapy, Highly Active</term><term>CD4 Lymphocyte Count</term><term>Coinfection</term><term>Female</term><term>Genotype</term><term>Humans</term><term>Longitudinal Studies</term><term>Male</term><term>Middle Aged</term><term>Sex Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Afrique de l'Ouest</term><term>Charge virale</term><term>Co-infection</term><term>Facteurs sexuels</term><term>Femelle</term><term>Génotype</term><term>Humains</term><term>Mâle</term><term>Numération des lymphocytes CD4</term><term>Résultat thérapeutique</term><term>Thérapie antirétrovirale hautement active</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term><term>Virus de l'hépatite B</term><term>Études longitudinales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Co-infection of HIV with HBV is common in West Africa but little information is available on the effects of HBV on short-term therapy for HIV patients. A 28 day longitudinal study was conducted to examine short-term antiretroviral therapy (ART) outcomes in HIV infected individuals with HBV co-infection.</div></front></TEI><affiliations><list><country><li>Ghana</li><li>États-Unis</li></country><region><li>Missouri (État)</li><li>Région du Grand Accra</li></region><settlement><li>Accra</li><li>Legon (Ghana)</li></settlement><orgName><li>Université du Ghana</li></orgName></list><tree><country name="Ghana"><region name="Région du Grand Accra"><name sortKey="Sagoe, Kwamena William Coleman" sort="Sagoe, Kwamena William Coleman" uniqKey="Sagoe K" first="Kwamena William Coleman" last="Sagoe">Kwamena William Coleman Sagoe</name></region><name sortKey="Adiku, Theophilus Korku" sort="Adiku, Theophilus Korku" uniqKey="Adiku T" first="Theophilus Korku" last="Adiku">Theophilus Korku Adiku</name><name sortKey="Agyei, Afrakoma Adjoa" sort="Agyei, Afrakoma Adjoa" uniqKey="Agyei A" first="Afrakoma Adjoa" last="Agyei">Afrakoma Adjoa Agyei</name><name sortKey="Duedu, Kwabena Obeng" sort="Duedu, Kwabena Obeng" uniqKey="Duedu K" first="Kwabena Obeng" last="Duedu">Kwabena Obeng Duedu</name><name sortKey="Lartey, Margaret" sort="Lartey, Margaret" uniqKey="Lartey M" first="Margaret" last="Lartey">Margaret Lartey</name><name sortKey="Mingle, Julius Abraham Addo" sort="Mingle, Julius Abraham Addo" uniqKey="Mingle J" first="Julius Abraham Addo" last="Mingle">Julius Abraham Addo Mingle</name><name sortKey="Ziga, Francesca" sort="Ziga, Francesca" uniqKey="Ziga F" first="Francesca" last="Ziga">Francesca Ziga</name></country><country name="États-Unis"><region name="Missouri (État)"><name sortKey="Arens, Max" sort="Arens, Max" uniqKey="Arens M" first="Max" last="Arens">Max Arens</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000146 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000146 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27251610
|texte= Short-term treatment outcomes in human immunodeficiency virus type-1 and hepatitis B virus co-infections.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27251610" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |